Time, Weeks | TH/LD Group, n = 30 | LD Group, n = 30 | p Intergroup |
---|---|---|---|
Cochin | 0.668 | ||
T0 | 19.3 (17.3)/13.1–25.4 | 23.1 (16.3)/17.0–29.3 | |
T1 | 17.8 (19.5)/11.2–24.4 | 22.1 (16.7)/15.5–28.7 | |
T4 | 14.3 (16.4)/8.3–20.4 | 19.9 (16.7)/13.8–25.9 | |
T8 | 15.9 (18.1)/9.6–22.2 | 20.5 (16.3)/14.2–26.8 | |
T12 | 14.3 (15.3)/8.4–20.1 | 21.8 (16.7)/15.9–27.6 | |
AUSCAN global | 0.501 | ||
T0 | 25.9 (15.1)/20.7–31.2 | 29.1 (13.4)/23.8–34.3 | |
T1 | 22.7 (13.8)/17.3–28.0 | 27.5 (15.2)/22.2–32.8 | |
T4 | 20.0 (13.9)/14.9–25.1 | 25.5 (14.0)/20.3–30.6 | |
T8 | 20.3 (14.6)/15.1–25.5 | 26.0 (14.0)/20.8–31.3 | |
T12 | 18.8 (14.1)/13.6–24.0 | 25.7 (14.4)/20.4–30.9 | |
AUSCAN subscale pain | 0.421 | ||
T0 | 8.8 (4.8)/7.2–10.5 | 9.2 (4.3)/7.5–10.9 | |
T1 | 7.0 (4.6)/5.2–8.7 | 8.3 (5.1)/6.5–10.0 | |
T4 | 5.9 (4.9)/4.1–7.8 | 7.8 (5.4)/5.9–9.7 | |
T8 | 6.0 (4.9)/4.2–7.7 | 8.3 (4.5)/6.6–10.0 | |
T12 | 5.3 (4.7)/3.6–7.1 | 7.0 (4.8)/5.2–8.7 | |
AUSCAN subscale stiffness | 0.487 | ||
T0 | 1.7 (1.4)/1.1–2.2 | 2.0 (1.5)/1.5–2.5 | |
T1 | 1.1 (1.3)/0.6–1.6 | 1.5 (1.5)/1.0–2.0 | |
T4 | 1.2 (1.5)/0.6–1.7 | 1.8 (1.5)/1.2–2.3 | |
T8 | 1.6 (1.4)/1.1–2.1 | 1.9 (1.2)/1.4–2.4 | |
T12 | 1.2 (1.4)/0.7–1.7 | 2.0 (1.4)/1.5–2.5 | |
AUSCAN subscale function | 0.714 | ||
T0 | 15.4 (10.4)/11.9–19.0 | 17.9 (8.9)/14.3–21.4 | |
T1 | 14.6 (9.5)/11.0–18.1 | 17.8 (9.7)/14.2–21.3 | |
T4 | 12.9 (8.9)/9.7–16.2 | 15.9 (8.9)/12.6–19.1 | |
T8 | 12.7 (9.5)/9.2–16.2 | 15.8 (9.7)/12.3–19.3 | |
T12 | 12.3 (9.8)/8.7–15.9 | 16.7 (9.8)/13.1–20.3 |
TH: triamcinolone hexacetonide; LD: lidocaine; Cochin: Cochin Hand Functional Scale; AUSCAN: AUStralian CANadian Osteoarthritis Hand Index.